Sphingosine-1-phosphate in the circulatory system: Cause and therapeutic target for vascular dysfunction?
Rudolf
R
Schubert
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002319:Cardiovascular System / Q000378:metabolism*; D004594:Electrophysiology; D006801:Humans; D008246:Lysophospholipids / Q000502:physiology*; D015221:Potassium Channels / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000502:physiology; D014666:Vasomotor System / Q000502:physiology*; D020741:rho GTP-Binding Proteins / Q000378:metabolism
D008246:Lysophospholipids; D015221:Potassium Channels; C060506:sphingosine 1-phosphate; D020741:rho GTP-Binding Proteins; D013110:Sphingosine; D002118:Calcium